Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-Sectional Research01:50

Cross-Sectional Research

12.2K
In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.2K
Longitudinal Research02:20

Longitudinal Research

13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

147
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
147
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

175
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
175
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

194
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
194
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

156
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
156

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Perceptions on the Use of Artificial Intelligence in Creating Clinical Research Documents: Survey Study.

JMIR AI·2026
Same author

Insights Informing Strategies for Optimizing the Collection of Clinical Trial Data.

Therapeutic innovation & regulatory science·2025
Same author

Measuring Patient Participation Burden in Clinical Outcome Assessments for Clinical Trials.

Therapeutic innovation & regulatory science·2025
Same author

Trends in the Burden for Patients Participating in Industry-Funded Clinical Trials.

Therapeutic innovation & regulatory science·2025
Same author

Promoting Diversity through an Understanding of Barriers and Drivers for Inclusive Clinical Trials.

Therapeutic innovation & regulatory science·2025
Same author

Adoption Maturity Model for Risk-based Quality Management (RBQM) in Clinical Trials.

Therapeutic innovation & regulatory science·2025

Related Experiment Video

Updated: Dec 29, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K

Differences in Clinical Research Perceptions and Experiences by Age Subgroup.

Annick Anderson1, Deborah Borfitz2, Kenneth Getz2,3

  • 1The Center for Information and Study on Clinical Research Participation (CISCRP), One Liberty Square, Suite 510, Boston, MA, 02109, USA. annickanderson@ciscrp.org.

Therapeutic Innovation & Regulatory Science
|February 3, 2020
PubMed
Summary

Understanding clinical trial participant views across age groups is key. Tailored engagement strategies addressing knowledge gaps and utilizing social media can improve participation, especially for older adults.

Keywords:
clinical researchpatient engagementperceptionstrial experiences

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.7K

Related Experiment Videos

Last Updated: Dec 29, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

4.2K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K
Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
07:40

Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design

Published on: May 31, 2021

3.7K

Area of Science:

  • Clinical Research
  • Patient Engagement
  • Health Sciences

Background:

  • Differing viewpoints of adult clinical trial participants across 5 age cohorts were assessed.
  • Identified misperceptions and burdens faced by clinical trial volunteers.
  • Provided age-specific feedback to study sponsors on engagement efforts.

Purpose of the Study:

  • To assess differing viewpoints of adult clinical trial participants in 5 age cohorts.
  • To identify misperceptions and opportunities to reduce volunteer burdens.
  • To provide age-specific feedback to study sponsors on engagement efforts.

Main Methods:

  • Global online survey with 12,427 responses collected May-July 2017.
  • Subgroup analysis by age for clinical research impressions and participation decision-making.
  • Examined experiences of study participants across different age groups.

Main Results:

  • Younger individuals were most misinformed and faced the most difficulties.
  • Older individuals expressed more misgivings about studies and pharmaceutical companies.
  • Compensation was a key motivator for middle-aged participants; social media and convenience were important across all ages.

Conclusions:

  • Targeted engagement addressing age-specific knowledge gaps and trial participation aspects is crucial.
  • Altruistic benefits and physician involvement resonate well across age groups.
  • Social media and technology are underutilized, particularly for engaging older populations.